Various advances in imaging are changing the clinical practice for Radiation Oncology.

One of the most exciting and rapidly evolving areas of radiation oncology is in its application to the settings of oligometastatic or metastatic disease. Some of the most significant progress has been in implementing local therapy in the management of oligometastatic NSCLC.

Cervical cancer continues to be a common cancer globally, especially in less developed regions and some underserved areas in the US where advanced stage presentations are common. Recently published clinical trials looked at addition of novel agents to standard chemoradiation.

This session highlights the most clinically relevant abstracts within the Gastrointestinal Cancer track of the 2023 ASTRO Annual Meeting scientific program.

While radiation therapy (RT) is a highly effective treatment for many solid tumors, thoracic RT carries a risk of cardiovascular (CV) morbidity and mortality that limits critical gains in cancer control and survival.

Ongoing advances in technology have allowed for the shrinkage of target volumes and lowering of doses in the treatment of lymphomas with radiation.

This session highlights the most clinically relevant abstracts within the Genitourinary Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.

This session highlights the most clinically relevant abstracts within the Head and Neck Cancer track of the 2023 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.

Several national societies' guidelines, including the National Comprehensive Cancer Network and the American Society of Clinical Oncology, recommend screening of older adults with cancer with a comprehensive geriatric assessment (CGA) or similar tools.

The role of RT in DLBCL is changing. Recent randomized studies have challenged the role of RT in the primary treatment of DLBCL but they included selected patient populations, making application of results in routine clinical practice difficult.